Currently, several prognostic biomarkers of breast cancer (e.g., hormone receptor status, HER-2 status, Ki-67 LI, p53 expression, and histologic grade) are considered to be sources of valuable information regarding tumor aggressiveness, as well as the likelihood of response to therapy. Here, MKI67 is linked to breast cancer.